HeartSciences (HSCS) Net Cash Flow Growth (3y) (2024 - 2026)
HeartSciences (HSCS) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | -48.90% |
| 10 | HeartSciences | 6.43 Mn | 4.73 Mn | - | -85.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -85.99% |
| Oct 31, 2025 | 11.08% |
| Jul 31, 2025 | -20.36% |
| Apr 30, 2025 | -54.04% |
| Jan 31, 2025 | -52.11% |
| Oct 31, 2024 | 27.92% |
| Jul 31, 2024 | -26.95% |